<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02584907</url>
  </required_header>
  <id_info>
    <org_study_id>1395/34199</org_study_id>
    <nct_id>NCT02584907</nct_id>
  </id_info>
  <brief_title>Fat Based Enteral Nutrition for Blood Glucose Control in ICU</brief_title>
  <official_title>Effect of Fat Based Versus Glucose Based Enteral Nutrition on Serum Glucose Levels and Clinical Outcome in Hyperglycemic Patients in ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this randomized, double-blind clinical trial, eligible hospitalized ICU patients with EN
      will be included. Patients will be divided into two groups. The control group with the
      standard EN and intervention group with high fat EN. 50% of the total fat will be provided by
      olive oil. Nutritional intake record form will be completed and daily calorie intake will be
      calculated. High fat EN feeding will be offered for 15 consecutive days maximally. At the end
      of the study mean blood glucose, duration of hospitalization and rate of infection will be
      compared in two groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this randomized, double-blind clinical trial, 88 eligible hospitalized ICU patients with
      EN will be included. Written consent form will be completed. Physical examination will be
      done by specialist and nutritional care process will be offered by an RD. Demographic,
      laboratory and nutritional data will be extracted and entered in prepared form. Venous blood
      samples will be taken and laboratory values will be measured and recorded at specified times.
      Patients will be divided into two groups. The control group with the standard EN (Protein;
      20% carbohydrate; 50% and fat; 30% from total calories) and intervention group with high fat
      EN (Protein; 20% carbohydrate; 35% and fat; 45% from total calories). 50% of the total fat
      will be provided by olive oil. Any feeding rout such as naso - gastric , Percutaneous
      endoscopic gastrostomy (PEG ) or Percutaneous endoscopic jejunostomy (PEJ) with Intermittent
      feeding protocol will be accepted feeding method . Nutritional intake record form will be
      completed and daily calorie intake will be calculated. High fat EN feeding will be offered
      for 15 consecutive days maximally
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">April 1, 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Glucose</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of Stay in ICU</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of Infection</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Hyperglycemia</condition>
  <arm_group>
    <arm_group_label>High Fat Enteral Nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diet in high fat group will be 20% from protein, 45% from fat and 35% from carbohydrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standered Enteral Nutrition</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Diet in standard group will be 20% from protein, 30% from fat and 50% from carbohydrate</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Fat Enteral Nutrition</intervention_name>
    <description>Diet in high fat group will be 20% from protein, 45% from fat and 35% from carbohydrate</description>
    <arm_group_label>High Fat Enteral Nutrition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being on Enteral Nutrition

          -  BSâ‰¥ 200mg/dl

          -  Without Renal and Liver Failure

          -  Without Hyperlipidemia and Nephrotic Syndrome

          -  Without Infection

          -  Without Obesity

        Exclusion Criteria:

          -  Death or Discharge before Day 7
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zahra Vahdat Shariatpanahi, MD, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Nutrition and Food Sciencees, Shahid Beheshti University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Nutrition Sciences and Food Technology</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <link>
    <url>http://www.ccforum.com</url>
    <description>Critical Care</description>
  </link>
  <reference>
    <citation>Wewalka M, Drolz A, Zauner C. Influence of fat-based versus glucose-based enteral nutrition formulas on glucose homeostasis. Crit Care. 2013; 17(Suppl 2): P250. Published online 2013 Mar 19. doi: 10.1186/cc12188. PMCID: PMC3642614.</citation>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2015</study_first_submitted>
  <study_first_submitted_qc>October 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2015</study_first_posted>
  <last_update_submitted>April 13, 2017</last_update_submitted>
  <last_update_submitted_qc>April 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shahid Beheshti University</investigator_affiliation>
    <investigator_full_name>Zahra Vahdat Shariatpanahi</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Critically ill</keyword>
  <keyword>Diet</keyword>
  <keyword>Blood glucose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

